Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

La Jolla Pharmaceutical Q2 net loss up

La Jolla Pharmaceutical Company, a biopharmaceutical company, has reported a net loss attributable to the common shareholders of $4.28 million, or $0.63 loss per share, for the second quarter ended June 30, 2014, compared to a net loss attributable to the common shareholders of $3.72 million, or $6.77 loss per share, for the same quarter ended June 30, 2013.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

Novozymes Q2 net profit increases

Novozymes A/S, a biotechnology company, has reported that net profit attributable to the shareholders for the second quarter ended June 30, 2014 was DKK591 million, or DKK1.87 per diluted share, compared to DKK555 million, or DKK1.75 per diluted share, for the same quarter ended June 30, 2013.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

Cyanotech appoints new COO

Cyanotech Corporation, a developer of microalgae technology, has appointed Gerard Watts as the new COO.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

WuXi PharmaTech reports lower Q2 net income, provides annual outlook

WuXi PharmaTech Inc. has reported a net income of $29.34 million, or $0.41 per diluted ADS, for the second quarter ended June 30, 2014, compared to $29.62 million, or $0.41 per diluted ADS, for the same quarter ended June 30, 2013. For 2014, the company expects GAAP diluted earnings per ADS to be in the range of $1.55 to $1.59.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

IMRIS receives three Japanese patents related to iMRI solution

IMRIS Inc., a provider of image guided therapy solutions, has received three patents related to the technology integrated into its intraoperative MRI, or iMRI, solution within the VISIUS Surgical Theatre from Japanese patent office.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

Cyanotech reports net loss for Q1

Cyanotech Corporation has reported a net loss of $413,000, or $0.08 loss per share, for the first quarter ended June 30, 2014, compared to a net income of $30,000, or $0.01 per share, for the same quarter ended June 30, 2013.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

Medical Facilities Q2 net income up

Medical Facilities Corporation has reported a net income and comprehensive income attributable to the owners of the corporation of $15.77 million, or $0.243 per diluted share, for the second quarter ended June 30, 2014, compared to $7.41 million, or $0.096 per diluted share, for the same quarter ended June 30, 2013.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

LHC Group elects new board member

LHC Group, Inc., a provider of post-acute healthcare services, has elected Brent Turner to its board of directors.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

PPD appoints executive vice president and CFO

Pharmaceutical Product Development, LLC, or PPD, a provider of drug discovery, development, lifecycle management and laboratory services, has appointed Robert Hureau as executive vice president and CFO.

Published By MarketLine
01 Sep 2014
NewsWire
NewsWire

Tecan Group H1 profit up

Tecan Group AG, a provider of laboratory instruments, has reported a profit of CHF18.58 million, or CHF1.65 per diluted share, for the first six months ended June 30, 2014, compared to CHF16.48 million, or CHF1.49 per diluted share, for the same period ended June 30, 2013.

Published By MarketLine
01 Sep 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.